Translations:Dulaglutide/20/ja

Revision as of 16:42, 12 February 2024 by Fire (talk | contribs) (Created page with "== Further reading == * {{cite journal | vauthors = Scott LJ | title = Dulaglutide: A Review in Type 2 Diabetes | journal = Drugs | volume = 80 | issue = 2 | pages = 197–208 | date = February 2020 | pmid = 32002850 | doi = 10.1007/s40265-020-01260-9 | s2cid = 210954338 }} * {{cite journal | vauthors = Edwards KL, Minze MG | title = Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes | journal = Core Evidence | volume = 10 | pages...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Further reading

Scott LJ (February 2020). "Dulaglutide: A Review in Type 2 Diabetes". Drugs. 80 (2): 197–208. doi:10.1007/s40265-020-01260-9. PMID 32002850. S2CID 210954338.
Edwards KL, Minze MG (2015). "Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes". Core Evidence. 10: 11–21. doi:10.2147/CE.S55944. PMC 4295897. PMID 25657615.
Romera I, Cebrián-Cuenca A, Álvarez-Guisasola F, Gomez-Peralta F, Reviriego J (February 2019). "A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes". Diabetes Therapy. 10 (1): 5–19. doi:10.1007/s13300-018-0535-9. PMC 6349277. PMID 30506340.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Dulaglutide/20/ja&oldid=113767"